AKT1 and breast cancer: The expression of AKT in HR + BC cells and xenografted tumors was examined through WB analysis, and we found a significant decrease in AKT and p-AKT expression in MCF7 and ZR-75-1 cells overexpressing RBP7, indicating that RBP7 could inhibit the AKT signaling pathway in HR + BC cells.